港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

百奧賽圖-B

23.120

-0.680-2.86%

成交量：9.85萬

成交額：231.36萬

市值：92.34億

市盈率：251.60

高：24.180

開：23.800

低：23.120

收：23.800

52周最高：31.340

52周最低：5.600

股本：3.99億

香港流通股本：1.11億

量比：0.78

換手率：0.09%

股息：- -

股息率：- -

每股收益(LYR):0.092

淨資產收益率：16.11%

總資產收益率：6.20%

市淨率：9.49

市盈率(LYR):251.59

市銷率: 7.11

資料載入中...

總覽公司新聞公告

異動解讀 | 基因編輯技術價值凸顯，百奧賽圖-B盤中大漲8.81%

異動解讀 | 百奧賽圖-B盤中大漲8.81%，中期業績亮眼顯示基因編輯技術價值

港股異動 | 百奧賽圖-B(02315)午前漲超5% 中期股東應占溢利4799.9萬元公司基因編輯技術價值凸顯

創新藥產業進入「兑現期」，百奧賽圖半年報釋放積極信號

BD交易數量領跑，中國Biotech的出海樣本—百奧賽圖半年報解析

抗風險能力強的BD數量之王，百奧賽圖多項經營數據顯著改善

異動解讀 | 百奧賽圖-B盤中大漲6.04%，中報營收增51.5%業績亮眼

中報營收大增51.5%，如何解碼百奧賽圖-B(02315)業績背後的稀缺性價值？

百奧賽圖-B(02315)發佈中期業績股東應占溢利4799.9萬元同比扭虧為盈

百奧賽圖-B08月25日主力淨流出34.4萬元散户資金買入

百奧賽圖與鎂伽科技達成戰略合作，「千鼠萬抗」開啓AI+自動化新時代

百奧賽圖-B盤中異動下午盤大幅上漲5.17%

借勢創新藥BD潮，抗體界「台積電」大器已成

生物醫藥行業研究報告：各部門合力推進商保建設助力創新藥械發展

百奧賽圖-B08月08日遭主力拋售49.2萬元

百奧賽圖：從「賣小鼠」到全球新藥「發源地」的裂變之旅

中国经济时报

百奧賽圖：扭虧難掩鉅虧陰影，港股暴跌74%後能否突圍科創板？

百奧賽圖（北京）醫藥科技股份有限公司中標轉基因小鼠庫項目

百奧賽圖-B盤中異動下午盤快速下挫5.15%報24.660港元

百奧賽圖科創板IPO：一百七十餘項財務數據呈現規律性變化

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02315/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02315","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02315\",,,,,undefined,":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奧賽圖-B","latestPrice":23.12,"timestamp":1761105217365,"preClose":23.8,"halted":0,"volume":98500,"delay":0,"floatShares":110781920,"shares":399398420,"eps":0.09189353538760442,"marketStatus":"午間休市","change":-0.68,"latestTime":"10-22 11:53:37","open":23.8,"high":24.18,"low":23.12,"amount":2313580,"amplitude":0.044538,"askPrice":23.14,"askSize":1500,"bidPrice":23,"bidSize":10000,"shortable":0,"etf":0,"ttmEps":0.3631372476627161,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1761109200000},"marketStatusCode":3,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":23.8,"openAndCloseTimeList":[[1761096600000,1761105600000],[1761109200000,1761120000000]],"volumeRatio":0.775104,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02315\",,,,,undefined,":{"symbol":"02315","floatShares":110781920,"roa":"6.20%","roe":"16.11%","lyrEps":0.091894,"volumeRatio":0.775104,"shares":399398420,"dividePrice":0,"high":24.18,"amplitude":0.044538,"preClose":23.8,"low":23.12,"week52Low":5.6,"pbRate":"9.49","psRate":"7.11","week52High":31.34,"institutionHeld":0,"latestPrice":23.12,"committee":0.73913,"eps":0.09189353538760442,"divideRate":0,"volume":98500,"delay":0,"ttmEps":0.3631372476627161,"open":23.8,"prevYearClose":8.5,"prevWeekClose":22.76,"prevMonthClose":28.48,"prevQuarterClose":28.48,"fiveDayClose":23.2,"twentyDayClose":27.4,"sixtyDayClose":21.45},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02315\",params:#limit:5,,,undefined,":[{"date":"2025-08-28","symbol":"02315","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-26","symbol":"02315","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"盤後","dateTimestamp":1742918400000,"actualEps":null},{"market":"HK","date":"2024-08-28","symbol":"02315","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1724774400000,"reportTimeType":"post","actualEps":null},{"date":"2024-03-27","symbol":"02315","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711503000000,"name":null,"time":"","dateTimestamp":1711468800000,"actualEps":null},{"date":"2023-08-28","symbol":"02315","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02315\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02315\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1743436800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02315\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02315","date":"2025-10-21","current":64.43135,"percent":0.82772,"low":-25.760101,"twenty":-15.115649,"median":-9.309059,"eighty":-5.888603,"high":292.060693,"avg":21.399895,"sd":76.373328,"marketCap":9505682396},"quantilePoints":[{"date":"2022-09-02","current":-17.320141,"twenty":-17.183465,"median":-16.97845,"eighty":-16.773436,"marketCap":10750256182},{"date":"2022-09-09","current":-16.423987,"twenty":-16.725792,"median":-16.549247,"eighty":-16.380597,"marketCap":10155223552},{"date":"2022-09-16","current":-16.318147,"twenty":-16.63676,"median":-16.36975,"eighty":-16.316556,"marketCap":9996548184},{"date":"2022-09-23","current":-16.637534,"twenty":-16.675139,"median":-16.58177,"eighty":-16.318147,"marketCap":9996548184},{"date":"2022-09-30","current":-16.676297,"twenty":-16.685959,"median":-16.63676,"eighty":-16.318147,"marketCap":10464238604},{"date":"2022-10-07","current":-16.709082,"twenty":-16.759103,"median":-16.644605,"eighty":-16.32635,"marketCap":10484208525},{"date":"2022-10-14","current":-17.016883,"twenty":-16.759103,"median":-16.64107,"eighty":-16.343742,"marketCap":10564088209},{"date":"2022-10-21","current":-17.166611,"twenty":-17.031627,"median":-16.675139,"eighty":-16.354867,"marketCap":10584058130},{"date":"2022-10-28","current":-16.904053,"twenty":-17.031627,"median":-16.675441,"eighty":-16.36536,"marketCap":10404328841},{"date":"2022-11-04","current":-16.612618,"twenty":-17.082341,"median":-16.676297,"eighty":-16.369306,"marketCap":10324449157},{"date":"2022-11-11","current":-16.306635,"twenty":-17.029879,"median":-16.67602,"eighty":-16.36536,"marketCap":10224599552},{"date":"2022-11-18","current":-16.746191,"twenty":-17.082341,"median":-16.685959,"eighty":-16.369306,"marketCap":10464238604},{"date":"2022-11-25","current":-16.976752,"twenty":-17.082341,"median":-16.684366,"eighty":-16.41314,"marketCap":10524148367},{"date":"2022-12-02","current":-16.467053,"twenty":-17.08023,"median":-16.682773,"eighty":-16.455087,"marketCap":10384358920},{"date":"2022-12-09","current":-16.284129,"twenty":-17.029868,"median":-16.675441,"eighty":-16.360668,"marketCap":10364388999},{"date":"2022-12-16","current":-16.102056,"twenty":-17.016962,"median":-16.650632,"eighty":-16.338699,"marketCap":10224599552},{"date":"2022-12-23","current":-16.065604,"twenty":-16.984778,"median":-16.637147,"eighty":-16.314572,"marketCap":10204629631},{"date":"2022-12-30","current":-15.934887,"twenty":-16.966494,"median":-16.614292,"eighty":-16.270012,"marketCap":10244569473},{"date":"2023-01-06","current":-15.64986,"twenty":-16.949062,"median":-16.590059,"eighty":-16.212217,"marketCap":10164689789},{"date":"2023-01-13","current":-15.537191,"twenty":-16.938757,"median":-16.549025,"eighty":-16.179981,"marketCap":10284509315},{"date":"2023-01-20","current":-15.580379,"twenty":-16.925026,"median":-16.534664,"eighty":-16.156179,"marketCap":10224599552},{"date":"2023-01-27","current":-15.546768,"twenty":-16.914539,"median":-16.533948,"eighty":-16.10098,"marketCap":10204629631},{"date":"2023-02-03","current":-15.436408,"twenty":-16.898489,"median":-16.443424,"eighty":-15.899534,"marketCap":10184659710},{"date":"2023-02-10","current":-15.407922,"twenty":-16.85946,"median":-16.367528,"eighty":-15.72674,"marketCap":10104780026},{"date":"2023-02-17","current":-15.462828,"twenty":-16.826005,"median":-16.357582,"eighty":-15.576487,"marketCap":10044870263},{"date":"2023-02-24","current":-15.747577,"twenty":-16.809749,"median":-16.341273,"eighty":-15.581234,"marketCap":10104780026},{"date":"2023-03-03","current":-16.543432,"twenty":-16.800921,"median":-16.334837,"eighty":-15.597252,"marketCap":10683907735},{"date":"2023-03-10","current":-15.544967,"twenty":-15.579303,"median":-15.560593,"eighty":-15.545027,"marketCap":9964990579},{"date":"2023-03-17","current":-15.303442,"twenty":-16.772422,"median":-16.316556,"eighty":-15.545905,"marketCap":9905080816},{"date":"2023-03-24","current":-15.373763,"twenty":-16.756627,"median":-16.272365,"eighty":-15.544864,"marketCap":10064840184},{"date":"2023-03-31","current":-14.490947,"twenty":-16.750261,"median":-16.244078,"eighty":-15.503171,"marketCap":9964990579},{"date":"2023-04-06","current":-14.616535,"twenty":-16.74805,"median":-16.201654,"eighty":-15.47105,"marketCap":10044870263},{"date":"2023-04-14","current":-14.718236,"twenty":-16.746563,"median":-16.189978,"eighty":-15.435882,"marketCap":10124749947},{"date":"2023-04-21","current":-14.522496,"twenty":-16.716504,"median":-16.166943,"eighty":-15.404922,"marketCap":9984960500},{"date":"2023-04-28","current":-14.543652,"twenty":-16.690584,"median":-16.159298,"eighty":-15.375204,"marketCap":9925050737},{"date":"2023-05-05","current":-14.549057,"twenty":-16.684047,"median":-16.100712,"eighty":-15.342097,"marketCap":9945020658},{"date":"2023-05-12","current":-14.620521,"twenty":-16.678887,"median":-16.039544,"eighty":-15.333905,"marketCap":9925050737},{"date":"2023-05-19","current":-14.943491,"twenty":-16.675965,"median":-15.890696,"eighty":-15.23178,"marketCap":9725351527},{"date":"2023-05-25","current":-14.912803,"twenty":-16.675501,"median":-15.809962,"eighty":-15.067549,"marketCap":9665441764},{"date":"2023-06-02","current":-14.437965,"twenty":-16.668929,"median":-15.747577,"eighty":-14.987375,"marketCap":9325953107},{"date":"2023-06-09","current":-14.613629,"twenty":-16.656022,"median":-15.667464,"eighty":-14.759824,"marketCap":9425802712},{"date":"2023-06-16","current":-13.688431,"twenty":-16.648221,"median":-15.639948,"eighty":-14.693346,"marketCap":8786765240},{"date":"2023-06-23","current":-13.012764,"twenty":-16.643191,"median":-15.607551,"eighty":-14.659979,"marketCap":8307487136},{"date":"2023-06-30","current":-13.257814,"twenty":-16.637379,"median":-15.582942,"eighty":-14.61421,"marketCap":8387366820},{"date":"2023-07-07","current":-12.682797,"twenty":-16.632266,"median":-15.576118,"eighty":-14.550185,"marketCap":8007938321},{"date":"2023-07-14","current":-12.819193,"twenty":-16.613957,"median":-15.551683,"eighty":-14.529885,"marketCap":8207637531},{"date":"2023-07-21","current":-12.973057,"twenty":-16.608106,"median":-15.545068,"eighty":-14.516129,"marketCap":8267547294},{"date":"2023-07-28","current":-12.535237,"twenty":-16.582609,"median":-15.540993,"eighty":-14.488236,"marketCap":7979980431},{"date":"2023-08-04","current":-11.938194,"twenty":-16.552097,"median":-15.522734,"eighty":-14.412097,"marketCap":7612533885},{"date":"2023-08-11","current":-10.431222,"twenty":-16.549158,"median":-15.479965,"eighty":-14.353579,"marketCap":6614037835},{"date":"2023-08-18","current":-9.656286,"twenty":-16.54773,"median":-15.439162,"eighty":-14.141185,"marketCap":6078843952},{"date":"2023-08-25","current":-10.146146,"twenty":-16.543346,"median":-15.430512,"eighty":-13.53248,"marketCap":6390374720},{"date":"2023-09-01","current":-12.99564,"twenty":-16.541336,"median":-15.407922,"eighty":-13.291047,"marketCap":7293015149},{"date":"2023-09-08","current":-12.315048,"twenty":-16.534521,"median":-15.387742,"eighty":-12.99529,"marketCap":6829712982},{"date":"2023-09-15","current":-10.219312,"twenty":-16.520569,"median":-15.373763,"eighty":-12.96537,"marketCap":5711397406},{"date":"2023-09-22","current":-10.063213,"twenty":-16.466215,"median":-15.341727,"eighty":-12.868104,"marketCap":5599565848},{"date":"2023-09-29","current":-11.178127,"twenty":-16.455087,"median":-15.334187,"eighty":-12.79424,"marketCap":6230615352},{"date":"2023-10-06","current":-9.993446,"twenty":-16.423987,"median":-15.333905,"eighty":-12.692866,"marketCap":5567613974},{"date":"2023-10-13","current":-9.290433,"twenty":-16.36975,"median":-15.303888,"eighty":-12.547785,"marketCap":5168215554},{"date":"2023-10-20","current":-8.010443,"twenty":-16.367528,"median":-15.102694,"eighty":-12.48935,"marketCap":4449298398},{"date":"2023-10-27","current":-8.488672,"twenty":-16.362478,"median":-15.063511,"eighty":-12.292711,"marketCap":4712901356},{"date":"2023-11-03","current":-8.710133,"twenty":-16.359022,"median":-15.056757,"eighty":-12.104621,"marketCap":4848696818},{"date":"2023-11-10","current":-8.898536,"twenty":-16.357046,"median":-14.912803,"eighty":-11.941145,"marketCap":4952540408},{"date":"2023-11-17","current":-8.747876,"twenty":-16.349399,"median":-14.761097,"eighty":-11.58475,"marketCap":4912600566},{"date":"2023-11-24","current":-9.071472,"twenty":-16.342534,"median":-14.718236,"eighty":-10.82373,"marketCap":5136263681},{"date":"2023-12-01","current":-8.640618,"twenty":-16.330975,"median":-14.677453,"eighty":-10.271499,"marketCap":4912600566},{"date":"2023-12-08","current":-7.758741,"twenty":-16.322161,"median":-14.658546,"eighty":-10.157974,"marketCap":4393382620},{"date":"2023-12-15","current":-7.349523,"twenty":-16.318638,"median":-14.616817,"eighty":-10.062883,"marketCap":4185695441},{"date":"2023-12-22","current":-8.126371,"twenty":-16.317676,"median":-14.584545,"eighty":-9.957278,"marketCap":4625033703},{"date":"2023-12-29","current":-8.362487,"twenty":-16.317157,"median":-14.562072,"eighty":-9.871741,"marketCap":4784793071},{"date":"2024-01-05","current":-7.803247,"twenty":-16.314572,"median":-14.547516,"eighty":-9.761569,"marketCap":4433322462},{"date":"2024-01-12","current":-7.461837,"twenty":-16.302134,"median":-14.536365,"eighty":-9.504477,"marketCap":4241611220},{"date":"2024-01-19","current":-7.035876,"twenty":-16.279423,"median":-14.522365,"eighty":-9.33176,"marketCap":3993984200},{"date":"2024-01-26","current":-6.794958,"twenty":-16.258464,"median":-14.515165,"eighty":-9.235745,"marketCap":3842212800},{"date":"2024-02-02","current":-6.280276,"twenty":-16.248749,"median":-14.494808,"eighty":-9.119832,"marketCap":3546657969},{"date":"2024-02-09","current":-6.080594,"twenty":-16.236113,"median":-14.46742,"eighty":-9.04289,"marketCap":3450802348},{"date":"2024-02-16","current":-6.100388,"twenty":-16.212217,"median":-14.448798,"eighty":-8.990936,"marketCap":3462784301},{"date":"2024-02-23","current":-5.580985,"twenty":-16.200095,"median":-14.377271,"eighty":-8.779882,"marketCap":3151253533},{"date":"2024-03-01","current":-6.821664,"twenty":-16.194567,"median":-14.359409,"eighty":-8.66879,"marketCap":3854194753},{"date":"2024-03-08","current":-6.691446,"twenty":-16.187898,"median":-14.283383,"eighty":-8.531038,"marketCap":3782303037},{"date":"2024-03-15","current":-7.256077,"twenty":-16.179981,"median":-13.930623,"eighty":-8.39945,"marketCap":4097827789},{"date":"2024-03-22","current":-6.151369,"twenty":-16.169224,"median":-13.579636,"eighty":-8.326104,"marketCap":3470772269},{"date":"2024-03-28","current":-8.333872,"twenty":-16.165922,"median":-13.45297,"eighty":-8.269405,"marketCap":3454796333},{"date":"2024-04-05","current":-6.804027,"twenty":-16.165092,"median":-13.428292,"eighty":-8.136639,"marketCap":2819752845},{"date":"2024-04-12","current":-6.357095,"twenty":-16.162416,"median":-13.25289,"eighty":-8.013058,"marketCap":2636029572},{"date":"2024-04-19","current":-7.133743,"twenty":-16.143691,"median":-12.995421,"eighty":-7.920902,"marketCap":2955548308},{"date":"2024-04-26","current":-8.011238,"twenty":-16.101518,"median":-12.982283,"eighty":-7.901825,"marketCap":3315006886},{"date":"2024-05-03","current":-8.4804,"twenty":-16.099367,"median":-12.963448,"eighty":-7.90259,"marketCap":3506718127},{"date":"2024-05-10","current":-9.394996,"twenty":-16.065604,"median":-12.898932,"eighty":-7.913843,"marketCap":3894134595},{"date":"2024-05-17","current":-9.215805,"twenty":-16.044756,"median":-12.867532,"eighty":-7.919339,"marketCap":3814254911},{"date":"2024-05-24","current":-9.246573,"twenty":-15.983649,"median":-12.819193,"eighty":-7.921471,"marketCap":3818248895},{"date":"2024-05-31","current":-8.589796,"twenty":-15.941845,"median":-12.752108,"eighty":-7.961158,"marketCap":3550651953},{"date":"2024-06-07","current":-7.768472,"twenty":-15.864181,"median":-12.691034,"eighty":-7.961158,"marketCap":3207169312},{"date":"2024-06-14","current":-7.814329,"twenty":-15.826431,"median":-12.62649,"eighty":-7.909342,"marketCap":3223145249},{"date":"2024-06-21","current":-7.277623,"twenty":-15.809345,"median":-12.53142,"eighty":-7.79631,"marketCap":2995488150},{"date":"2024-06-28","current":-7.426256,"twenty":-15.789546,"median":-12.48935,"eighty":-7.753383,"marketCap":3055397913},{"date":"2024-07-05","current":-7.495836,"twenty":-15.765827,"median":-12.315048,"eighty":-7.684126,"marketCap":3083355802},{"date":"2024-07-12","current":-7.223066,"twenty":-15.726554,"median":-12.278434,"eighty":-7.629416,"marketCap":2975518229},{"date":"2024-07-19","current":-7.193846,"twenty":-15.685816,"median":-12.106939,"eighty":-7.601973,"marketCap":2963536276},{"date":"2024-07-26","current":-6.703571,"twenty":-15.668373,"median":-11.984006,"eighty":-7.505156,"marketCap":2771825034},{"date":"2024-08-02","current":-6.523845,"twenty":-15.657694,"median":-11.938194,"eighty":-7.459727,"marketCap":2695939335},{"date":"2024-08-09","current":-5.9622,"twenty":-15.645895,"median":-11.636139,"eighty":-7.412301,"marketCap":2480264188},{"date":"2024-08-16","current":-6.420552,"twenty":-15.638291,"median":-11.199705,"eighty":-7.36919,"marketCap":2671975429},{"date":"2024-08-23","current":-6.211949,"twenty":-15.624504,"median":-10.786048,"eighty":-7.29332,"marketCap":2596089730},{"date":"2024-08-30","current":-9.587395,"twenty":-15.607156,"median":-10.431222,"eighty":-7.274264,"marketCap":2568131840},{"date":"2024-09-06","current":-9.344329,"twenty":-15.59757,"median":-10.232292,"eighty":-7.282379,"marketCap":2504228093},{"date":"2024-09-13","current":-8.935525,"twenty":-15.58317,"median":-10.160931,"eighty":-7.29332,"marketCap":2388402551},{"date":"2024-09-20","current":-9.357565,"twenty":-15.581519,"median":-10.098938,"eighty":-7.308194,"marketCap":2516210046},{"date":"2024-09-27","current":-10.320372,"twenty":-15.579527,"median":-10.073832,"eighty":-7.345779,"marketCap":2791794955},{"date":"2024-10-04","current":-14.698364,"twenty":-15.576118,"median":-10.122542,"eighty":-7.349523,"marketCap":3958038342},{"date":"2024-10-10","current":-11.132217,"twenty":-15.571743,"median":-10.161683,"eighty":-7.362761,"marketCap":2979512213},{"date":"2024-10-18","current":-10.459714,"twenty":-15.559408,"median":-10.219312,"eighty":-7.372309,"marketCap":2783806987},{"date":"2024-10-25","current":-10.340316,"twenty":-15.548734,"median":-10.261664,"eighty":-7.392688,"marketCap":2751855113},{"date":"2024-11-01","current":-9.358506,"twenty":-15.545617,"median":-10.176873,"eighty":-7.401158,"marketCap":2492246140},{"date":"2024-11-08","current":-9.082377,"twenty":-15.54512,"median":-10.153538,"eighty":-7.405713,"marketCap":2400384504},{"date":"2024-11-15","current":-9.288588,"twenty":-15.544987,"median":-10.084452,"eighty":-7.417986,"marketCap":2436330362},{"date":"2024-11-22","current":-8.63879,"twenty":-15.54483,"median":-10.062389,"eighty":-7.42517,"marketCap":2264589041},{"date":"2024-11-29","current":-8.902865,"twenty":-15.538712,"median":-9.993446,"eighty":-7.43744,"marketCap":2332486772},{"date":"2024-12-06","current":-9.336462,"twenty":-15.534727,"median":-9.926941,"eighty":-7.454703,"marketCap":2440324346},{"date":"2024-12-13","current":-12.12859,"twenty":-15.525009,"median":-9.993446,"eighty":-7.461134,"marketCap":3167229470},{"date":"2024-12-20","current":-12.949109,"twenty":-15.49665,"median":-10.062389,"eighty":-7.463103,"marketCap":3362934696},{"date":"2024-12-27","current":-13.005336,"twenty":-15.48963,"median":-10.080954,"eighty":-7.464331,"marketCap":3374916649},{"date":"2025-01-03","current":-12.469835,"twenty":-15.485315,"median":-10.098938,"eighty":-7.471726,"marketCap":3239121186},{"date":"2025-01-10","current":-11.884455,"twenty":-15.469406,"median":-10.153538,"eighty":-7.500496,"marketCap":3075367834},{"date":"2025-01-17","current":-11.658965,"twenty":-15.458095,"median":-10.176873,"eighty":-7.522658,"marketCap":3019452055},{"date":"2025-01-24","current":-12.076794,"twenty":-15.438611,"median":-10.261664,"eighty":-7.541025,"marketCap":3147259549},{"date":"2025-01-28","current":-12.004152,"twenty":-15.43751,"median":-10.281809,"eighty":-7.549574,"marketCap":3143265565},{"date":"2025-02-07","current":-11.806203,"twenty":-15.434831,"median":-10.340316,"eighty":-7.578575,"marketCap":3075367834},{"date":"2025-02-14","current":-12.541461,"twenty":-15.429859,"median":-10.454096,"eighty":-7.606855,"marketCap":3259091107},{"date":"2025-02-21","current":-13.329047,"twenty":-15.417717,"median":-10.628219,"eighty":-7.62064,"marketCap":3482754222},{"date":"2025-02-28","current":-14.093919,"twenty":-15.409299,"median":-10.676284,"eighty":-7.632465,"marketCap":3670471479},{"date":"2025-03-07","current":-18.299233,"twenty":-15.417717,"median":-10.848852,"eighty":-7.647988,"marketCap":4784793071},{"date":"2025-03-14","current":-20.796737,"twenty":-15.448628,"median":-11.155172,"eighty":-7.670492,"marketCap":5439806480},{"date":"2025-03-21","current":-24.073812,"twenty":-15.503171,"median":-11.213505,"eighty":-7.682665,"marketCap":6294519099},{"date":"2025-03-28","current":166.890984,"twenty":-15.535343,"median":-11.265741,"eighty":-7.670492,"marketCap":5990976300},{"date":"2025-04-03","current":148.592565,"twenty":-15.52956,"median":-11.188916,"eighty":-7.619299,"marketCap":5335962891},{"date":"2025-04-11","current":137.813994,"twenty":-15.509692,"median":-11.08181,"eighty":-7.526181,"marketCap":4904612597},{"date":"2025-04-17","current":132.251881,"twenty":-15.489879,"median":-10.723244,"eighty":-7.463876,"marketCap":4712901356},{"date":"2025-04-25","current":130.653866,"twenty":-15.488881,"median":-10.665186,"eighty":-7.440236,"marketCap":4664973545},{"date":"2025-05-02","current":155.157263,"twenty":-15.474616,"median":-10.628219,"eighty":-7.405713,"marketCap":5551638038},{"date":"2025-05-09","current":134.566778,"twenty":-15.466117,"median":-10.459714,"eighty":-7.370749,"marketCap":4848696818},{"date":"2025-05-16","current":132.156923,"twenty":-15.448628,"median":-10.385769,"eighty":-7.295224,"marketCap":4800769008},{"date":"2025-05-23","current":176.26836,"twenty":-15.43751,"median":-10.285563,"eighty":-7.262732,"marketCap":6422326593},{"date":"2025-05-30","current":194.268841,"twenty":-15.434831,"median":-10.232292,"eighty":-7.240227,"marketCap":7109291876},{"date":"2025-06-06","current":190.508609,"twenty":-15.429859,"median":-10.162435,"eighty":-7.194033,"marketCap":6989472350},{"date":"2025-06-13","current":242.122352,"twenty":-15.417717,"median":-10.132322,"eighty":-7.161917,"marketCap":8886614845},{"date":"2025-06-20","current":239.872041,"twenty":-15.409299,"median":-10.084452,"eighty":-7.088113,"marketCap":8786765240},{"date":"2025-06-27","current":246.269522,"twenty":-15.398923,"median":-10.062389,"eighty":-7.044514,"marketCap":9046374213},{"date":"2025-07-04","current":250.063256,"twenty":-15.391199,"median":-10.003136,"eighty":-7.007459,"marketCap":9186163660},{"date":"2025-07-11","current":230.181341,"twenty":-15.387916,"median":-9.934047,"eighty":-6.832291,"marketCap":8447276583},{"date":"2025-07-18","current":234.173998,"twenty":-15.382348,"median":-9.913676,"eighty":-6.798586,"marketCap":8587066030},{"date":"2025-07-25","current":225.72884,"twenty":-15.374844,"median":-9.853307,"eighty":-6.692805,"marketCap":8307487136},{"date":"2025-08-01","current":277.909452,"twenty":-15.373763,"median":-9.815898,"eighty":-6.59652,"marketCap":10164689789},{"date":"2025-08-08","current":261.421777,"twenty":-15.361688,"median":-9.735143,"eighty":-6.513228,"marketCap":9585562080},{"date":"2025-08-15","current":268.795789,"twenty":-15.342097,"median":-9.631387,"eighty":-6.417235,"marketCap":9841177068},{"date":"2025-08-22","current":273.580909,"twenty":-15.337645,"median":-9.532105,"eighty":-6.350598,"marketCap":9984960500},{"date":"2025-08-29","current":62.555475,"twenty":-15.334252,"median":-9.483572,"eighty":-6.272638,"marketCap":9042380228},{"date":"2025-09-05","current":69.200112,"twenty":-15.334074,"median":-9.453998,"eighty":-6.171457,"marketCap":9992948468},{"date":"2025-09-12","current":63.498906,"twenty":-15.333905,"median":-9.423977,"eighty":-6.10359,"marketCap":9186163660},{"date":"2025-09-19","current":75.976522,"twenty":-15.323094,"median":-9.37227,"eighty":-6.060838,"marketCap":10983456550},{"date":"2025-09-26","current":79.221129,"twenty":-15.305861,"median":-9.358035,"eighty":-6.019236,"marketCap":11422794812},{"date":"2025-10-03","current":75.937529,"twenty":-15.304156,"median":-9.345758,"eighty":-5.969828,"marketCap":10975468581},{"date":"2025-10-10","current":69.406568,"twenty":-15.303442,"median":-9.33177,"eighty":-5.941754,"marketCap":10016912373},{"date":"2025-10-17","current":63.035254,"twenty":-15.124286,"median":-9.321633,"eighty":-5.913943,"marketCap":9090308039},{"date":"2025-10-21","current":65.898852,"twenty":-15.115649,"median":-9.309059,"eighty":-5.888603,"marketCap":9505682396}],"updateTime":1761102627646},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02315\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1133812477","title":"異動解讀 | 基因編輯技術價值凸顯，百奧賽圖-B盤中大漲8.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133812477","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1133812477?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 15:36","pubTimestamp":1756885004,"startTime":"0","endTime":"0","summary":"港股上市公司百奥赛图-B今日盘中大涨8.81%，引发市场广泛关注。截至发稿，该股报价25.56港元，成交额达1402万港元。此轮涨势主要受公司近期发布的亮眼中期业绩推动。百奥赛图-B公布截至2025年6月30日止6个月的财报显示，集团收益达人民币6.21亿元，同比增长51.3%；股东应占溢利4799.9万元，实现扭亏为盈。市场分析人士指出，百奥赛图-B凭借全球领先的基因编辑技术，成功构建了以创新动物模型和抗体分子转让开发为核心的双引擎增长模式。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"gpt_icon":0},{"id":"1140575460","title":"異動解讀 | 百奧賽圖-B盤中大漲8.81%，中期業績亮眼顯示基因編輯技術價值","url":"https://stock-news.laohu8.com/highlight/detail?id=1140575460","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140575460?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 15:36","pubTimestamp":1756885003,"startTime":"0","endTime":"0","summary":"港股百奥赛图-B今日盘中大涨8.81%，引发市场广泛关注。截至下午3点28分，该股报价25.56港元，成交量达56.35万股，总成交额1402万港元。消息面上，百奥赛图-B近日发布2025年上半年业绩报告，显示公司业绩大幅改善。分析指出，百奥赛图凭借全球领先的基因编辑技术，成功构建了以创新动物模型和抗体分子转让开发为核心的双引擎增长模式。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"gpt_icon":0},{"id":"2564356252","title":"港股異動 | 百奧賽圖-B(02315)午前漲超5% 中期股東應占溢利4799.9萬元 公司基因編輯技術價值凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2564356252","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564356252?lang=zh_tw&edition=fundamental","pubTime":"2025-09-03 11:54","pubTimestamp":1756871697,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B午前涨超5%，截至发稿，涨4.83%，报24.76港元，成交额744.04万港元。消息面上，近日，百奥赛图-B发布截至2025年6月30日止6个月中期业绩，集团收益人民币6.21亿元，同比增长51.3%；股东应占溢利4799.9万元，同比扭亏为盈；每股盈利0.12元。作为公司业绩增长的另一核心驱动力，抗体发现业务2025年上半年实现营业收入人民币1.63亿元，较去年同期增长37.8%，毛利率约90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1340893.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2564368579","title":"創新藥產業進入「兑現期」，百奧賽圖半年報釋放積極信號","url":"https://stock-news.laohu8.com/highlight/detail?id=2564368579","media":"同壁财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564368579?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 19:41","pubTimestamp":1756813279,"startTime":"0","endTime":"0","summary":"随着全球创新药产业继续深化分工，百奥赛图凭借“双产品驱动、国际化布局和高研发投入”，有望在未来的竞争格局中，持续强化其作为“全球新药发源地”的定位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902195720a4afa9cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902195720a4afa9cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","06978","02315"],"gpt_icon":0},{"id":"2564136856","title":"BD交易數量領跑，中國Biotech的出海樣本—百奧賽圖半年報解析","url":"https://stock-news.laohu8.com/highlight/detail?id=2564136856","media":"同壁财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564136856?lang=zh_tw&edition=fundamental","pubTime":"2025-09-02 19:37","pubTimestamp":1756813040,"startTime":"0","endTime":"0","summary":"近五年，License-out交易已经成为全球Biotech的核心关键词。通过全人抗体小鼠，百奥赛图构建了覆盖1000多个靶点的抗体分子库，总量超过百万条。交易数量与全球合作的拓展百奥赛图的BD合作并不限于数量，更体现在质量与覆盖面上。通过“千鼠万抗”平台和规模化的抗体分子库，公司在交易数量上保持领先，并逐步形成国际化合作网络。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902195703a4afa9aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250902195703a4afa9aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2563007071","title":"抗風險能力強的BD數量之王，百奧賽圖多項經營數據顯著改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2563007071","media":"明大教主","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563007071?lang=zh_tw&edition=fundamental","pubTime":"2025-08-30 07:01","pubTimestamp":1756508479,"startTime":"0","endTime":"0","summary":"2021H1至今，百奥赛图营收年化复合增速约47.5%。至6月末，百奥赛图已累计获得195项授权专利，提交496项专利申请。02 千鼠万抗成就百奥赛图国内BD数量“无冕之王”至中报披露日，百奥赛图“千鼠万抗”计划已针对超1000种靶点建立超100万条全人抗体序列库。国内创新药企拥有了充足的子弹研发新管线，将助推百奥赛图抗体分子授权业务放量。百奥赛图披露其模型动物绝大多数收入都是由人源化小鼠贡献，与其他国内同行具有显著差异。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830070359a4a8a9e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250830070359a4a8a9e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161","06978","BK1574"],"gpt_icon":0},{"id":"1188005018","title":"異動解讀 | 百奧賽圖-B盤中大漲6.04%，中報營收增51.5%業績亮眼","url":"https://stock-news.laohu8.com/highlight/detail?id=1188005018","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188005018?lang=zh_tw&edition=fundamental","pubTime":"2025-08-29 09:33","pubTimestamp":1756431195,"startTime":"0","endTime":"0","summary":"百奥赛图-B今日盘中大涨6.04%，引发市场关注。公司股价的强劲表现与其近期发布的亮眼中期业绩密切相关。根据公司发布的2025年中期报告，百奥赛图-B上半年实现营收6.21亿元，同比大幅增长51.5%。百奥赛图-B的优异业绩主要得益于其独特的\"创新动物模型+抗体分子转让\"双轮驱动商业模式。此外，公司还积极布局海外市场，不断强化技术优势和专利保护，进一步巩固了其在行业中的领先地位。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"gpt_icon":0},{"id":"2563939810","title":"中報營收大增51.5%，如何解碼百奧賽圖-B(02315)業績背後的稀缺性價值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2563939810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563939810?lang=zh_tw&edition=fundamental","pubTime":"2025-08-29 08:30","pubTimestamp":1756427415,"startTime":"0","endTime":"0","summary":"行业景气度持续攀升，百奥赛图-B股价表现尤为突出。与此同时，百奥赛图持续加快国际化布局，通过拓展海外市场增强盈利能力与抗风险韧性。同时，百奥赛图高度重视知识产权保护，已围绕核心技术与平台建立了完善的全球专利网络。随着未来百奥赛图加速确立其“全球新药发源地”的行业地位，其长期成长价值和投资吸引力正持续提升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1337303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315"],"gpt_icon":0},{"id":"2562413089","title":"百奧賽圖-B(02315)發佈中期業績 股東應占溢利4799.9萬元 同比扭虧為盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2562413089","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562413089?lang=zh_tw&edition=fundamental","pubTime":"2025-08-28 16:38","pubTimestamp":1756370303,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百奥赛图-B 发布截至2025年6月30日止6个月中期业绩，集团收益人民币6.21亿元，同比增长51.3%;股东应占溢利4799.9万元，同比扭亏为盈;每股盈利0.12元。2025年上半年，以创新动物模型销售为核心的临床前产品与服务业务实现营业收入人民币4.58亿元，较去年同期增长 56.9%，同时毛利率保持在约70%的高水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1337190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百奥赛图-B(02315)发布中期业绩 股东应占溢利4799.9万元 同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2562023788","title":"百奧賽圖-B08月25日主力淨流出34.4萬元 散户資金買入","url":"https://stock-news.laohu8.com/highlight/detail?id=2562023788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562023788?lang=zh_tw&edition=fundamental","pubTime":"2025-08-25 16:15","pubTimestamp":1756109712,"startTime":"0","endTime":"0","summary":"08月25日, 百奥赛图-B股价跌8.32%，报收22.92元，成交金额940.2万元，换手率0.37%，振幅12.48%，量比1.04。百奥赛图-B今日主力资金净流出34.4万元，上一交易日主力净流入39.6万元。该股近5个交易日下跌5.45%，主力资金累计净流入5.3万元；近20日主力资金累计净流出898.2万元，其中净流出天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250825165928a6fa090c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250825165928a6fa090c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2558634726","title":"百奧賽圖與鎂伽科技達成戰略合作，「千鼠萬抗」開啓AI+自動化新時代","url":"https://stock-news.laohu8.com/highlight/detail?id=2558634726","media":"新浪证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558634726?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 15:15","pubTimestamp":1754896500,"startTime":"0","endTime":"0","summary":"▲百奥赛图与镁伽科技签署战略合作协议百奥赛图作为一家以创新技术驱动新药研发的国际性生物技术公司，建立了涵盖靶点发现、全人抗体序列分子开发、临床前评估及合作转化的全链条一体化研发平台，通过“千鼠万抗TM”计划实现了覆盖千余靶点、超百万全人抗体序列分子的规模化开发，能够持续为全球药企及生物技术公司提供高质量的抗体序列分子，赋能双/多抗、ADC、纳米抗体、细胞治疗等多种药物形式的开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081115163397405dd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081115163397405dd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2558163100","title":"百奧賽圖-B盤中異動 下午盤大幅上漲5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558163100","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558163100?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 14:19","pubTimestamp":1754893157,"startTime":"0","endTime":"0","summary":"2025年08月11日下午盘14时19分，百奥赛图-B股票出现异动，股价快速拉升5.17%。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.76%。2024年至2025年上半年，百奥赛图持续盈利，核心的增长动能便是抗体分子授权交易。2025年上半年，百奥赛图持续在BD上发力。据医药魔方NextPharma数据库，百奥赛图已披露的BD交易就有3起，分别和育世博、Sotio和百济神州达成合作，稳定居于中国创新药对外授权交易第一梯队。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811141918974048e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811141918974048e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2558687871","title":"借勢創新藥BD潮，抗體界「台積電」大器已成","url":"https://stock-news.laohu8.com/highlight/detail?id=2558687871","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558687871?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 07:54","pubTimestamp":1754870043,"startTime":"0","endTime":"0","summary":"就此而言，近年来屡屡接下BD单子的百奥赛图，就是凭借自身在抗体药物发现环节的原创技术和平台创新能力，及其炼就的庞大、独特的抗体序列库，逐步成为全球抗体药物创新链条中的基础设施。BD捕手炼成记2024年至2025年上半年，百奥赛图持续盈利，核心的增长动能便是抗体分子授权交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811075933a6de651e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811075933a6de651e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1574","BK1161","06978"],"gpt_icon":0},{"id":"2558658541","title":"生物醫藥行業研究報告：各部門合力推進商保建設 助力創新藥械發展","url":"https://stock-news.laohu8.com/highlight/detail?id=2558658541","media":"平安证券","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558658541?lang=zh_tw&edition=fundamental","pubTime":"2025-08-11 00:00","pubTimestamp":1754841600,"startTime":"0","endTime":"0","summary":"创新药械的发展，需要数据、政策、资金等要素的深度融合，座谈会明确要打通医保数据与研发的协同通道。结合此前对商业健康险发展的政策支持，以及7月11日首次增加商业健康保险创新药目录等措施，将从资金面为我国创新药械发展带来增量。金融监督管理总局发布促进商保发展，与医保局形成合力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811164620a6df4231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811164620a6df4231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","LU0405327148.USD","LU2495084118.USD","WXIBF","LU2148510915.USD","BK0060","603259","LU2580892789.USD","BK0012","399265","LU1969619763.USD","688293","SBHMY","LU2488822045.USD","LU1997245094.SGD","LU2328871848.SGD","688271","BK0196","399441","LU1255011170.USD","LU2580892862.HKD","06821","600276","06160","LU1997245177.USD","02359","00512","688235","01177","LU1655091616.SGD","BK0188","01530","688687","LU1064130708.USD","02269","161726","688046","ONC","LU1064131003.USD","BK0183","LU0405327494.USD","BK0028","LU1997244956.HKD","02315","LU1328615791.USD"],"gpt_icon":0},{"id":"2557523336","title":"百奧賽圖-B08月08日遭主力拋售49.2萬元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557523336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557523336?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 16:15","pubTimestamp":1754640942,"startTime":"0","endTime":"0","summary":"08月08日, 百奥赛图-B股价跌2.36%，报收24.00元，成交金额578.5万元，换手率0.22%，振幅2.93%，量比0.37。百奥赛图-B今日主力资金净流出49.2万元，上一交易日主力净流出11.3万元。该股近5个交易日下跌5.70%，主力资金累计净流入139.6万元；近20日主力资金累计净流出376.2万元，其中净流出天数为4日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808174102a47cfa2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808174102a47cfa2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2557154549","title":"百奧賽圖：從「賣小鼠」到全球新藥「發源地」的裂變之旅","url":"https://stock-news.laohu8.com/highlight/detail?id=2557154549","media":"中国经济时报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557154549?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 15:58","pubTimestamp":1754639890,"startTime":"0","endTime":"0","summary":"从基因编辑小鼠模型起家，百奥赛图如今已成为全球药企眼中不可或缺的“新药发动机”——其抗体发现平台规模化输出的抗体分子，正构成全球新药创新的“基础设施”。在抗体授权业务中，其“千鼠万抗”抗体分子库已经成为跨国药企的重要“战略储备”。2025年年初，百奥赛图与SOTIO达成抗体授权协议；7月，公司与百济神州达成重磅的全球抗体授权协议。百奥赛图不再是技术提供者，而是“新药源头提供者”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808161402a47cc5ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808161402a47cc5ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2557519889","title":"百奧賽圖：扭虧難掩鉅虧陰影，港股暴跌74%後能否突圍科創板？","url":"https://stock-news.laohu8.com/highlight/detail?id=2557519889","media":"中金在线","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557519889?lang=zh_tw&edition=fundamental","pubTime":"2025-08-08 09:55","pubTimestamp":1754618150,"startTime":"0","endTime":"0","summary":"从财务数据来看，虽然百奥赛图在2024年报告了3354万元的净利润，看似取得了突破性的进展，但这背后隐藏着巨大的风险。截至2024年末，公司账面货币资金仅为3.84亿元，而短期债务却高达2.52亿元，加上实控人即将到期的8900万元高息借款，百奥赛图的资金链紧张程度可见一斑。除了财务健康度堪忧外，百奥赛图在市场表现上也遭遇了重大挫折。更令人不安的是，百奥赛图还面临着一系列可能阻碍其科创板上市的风险因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101032a47c175c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808101032a47c175c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HSTECH","HSCEI","BK1161","02315"],"gpt_icon":1},{"id":"2557557516","title":"百奧賽圖（北京）醫藥科技股份有限公司中標轉基因小鼠庫項目","url":"https://stock-news.laohu8.com/highlight/detail?id=2557557516","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557557516?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 18:20","pubTimestamp":1754562003,"startTime":"0","endTime":"0","summary":"天眼查App显示，2025年8月6日，首都医学科学创新中心发布‘转基因小鼠库第一批（二次）中标结果公告’。公告显示，百奥赛图（北京）医药科技股份有限公司以57万元人民币的中标金额成功中标该项目。此次招标项目由首都医学科学创新中心发起，位于北京市。公告类型为中标结果公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080718265794d55ec7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080718265794d55ec7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","BK1574","02315","09939"],"gpt_icon":0},{"id":"2557535882","title":"百奧賽圖-B盤中異動 下午盤快速下挫5.15%報24.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557535882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557535882?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 13:12","pubTimestamp":1754543530,"startTime":"0","endTime":"0","summary":"2025年08月07日下午盘13时12分，百奥赛图-B股票出现异动，股价大幅跳水5.15%。百奥赛图-B股票所在的生物技术行业中，整体跌幅为3.74%。该信息摘要如下：百奥赛图正是在这个时点交出了一份逆势增长的成绩单：预计2025年上半年营业收入约为6.16亿-6.26亿元，同比增长约50.1%-52.5%。值得注意的是，百奥赛图预计今年上半年净利润约为4270万-5270万元，同比实现扭亏为盈。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508071312119738f18a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508071312119738f18a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2557158770","title":"百奧賽圖科創板IPO：一百七十餘項財務數據呈現規律性變化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557158770","media":"估值之家","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557158770?lang=zh_tw&edition=fundamental","pubTime":"2025-08-07 10:56","pubTimestamp":1754535394,"startTime":"0","endTime":"0","summary":"鉴于国内众多CRO企业纷纷选择终止IPO，百奥赛图作为唯二仍在IPO进程中的公司尤为引人瞩目。估值之家通过对百奥赛图招股书及其他相关公开资料的研究，从纯财务角度，对发行人2024年度的首次扭亏真相及相关可能的财务问题加以剖析，以便广大投资者从深度财务视角，更加客观理性看待发行人的本次科创板的二次IPO。发行人作为一家港股主板CRO上市企业，出现如此大面积营业收入类数据的规律性变化，即便是放到科创板而言，可能也是不多见。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807110044a6d7c080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807110044a6d7c080&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","BK1161","02315","09939"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":153,"code":"91000000","status":"200"}]}}